STOCK TITAN

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Myriad Genetics (NASDAQ: MYGN) said its management will participate in two investor healthcare conferences in late 2025. Wolfe Research Healthcare Conference — fireside chat on Nov. 18, 2025 at 1:20 pm ET. Piper Sandler Healthcare Conference — fireside chat on Dec. 2, 2025 at 12:00 pm ET. Both presentations will be available via live audio webcasts in the investor information section at investor.myriad.com.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

+3.09%
1 alert
+3.09% News Effect

On the day this news was published, MYGN gained 3.09%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

SALT LAKE CITY, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences.

  • The 7th Annual Wolfe Research Healthcare Conference with a fireside chat on Tuesday, Nov. 18, 2025, at 1:20 pm ET.

  • The 37th Annual Piper Sandler Healthcare Conference with a fireside chat on Tuesday, Dec. 2, 2025, at 12:00 pm ET.

The presentations will be available through live audio webcast links in the investor information section of Myriad’s website at investor.myriad.com

About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.

Investor Contact 
Matt Scalo 
(801) 584-3532 
IR@myriad.com 

Media Contact 
Kate Schraml
(224) 875-4493
PR@myriad.com


FAQ

When will Myriad Genetics (MYGN) present at the Wolfe Research Healthcare Conference?

Myriad will present on Nov. 18, 2025 at 1:20 pm ET with a fireside chat.

What time is Myriad Genetics (MYGN) scheduled for the Piper Sandler Healthcare Conference?

Myriad is scheduled for a fireside chat on Dec. 2, 2025 at 12:00 pm ET.

How can investors watch Myriad Genetics (MYGN) conference presentations?

Presentations will stream via live audio webcast on the investor site at investor.myriad.com.

Are Myriad Genetics (MYGN) conference events live or pre-recorded?

The company announced the events as live fireside chats with audio webcasts.

Will Myriad Genetics (MYGN) provide slides or replay for the Nov. 18 and Dec. 2 presentations?

The announcement specifies live audio webcasts; check investor.myriad.com for any slides or replay availability.
Myriad Genetics

NASDAQ:MYGN

MYGN Rankings

MYGN Latest News

MYGN Latest SEC Filings

MYGN Stock Data

418.53M
93.21M
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
SALT LAKE CITY